| Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit | |
| Cao, Bo; Fang, Ziling; Liao, Peng; Zhou, Xiang; Xiong, Jianping; Zeng, Shelya; Lu, Hua | |
| 刊名 | ONCOTARGET
 |
| 2017 | |
| 卷号 | 8期号:53 |
| 关键词 | RPL22/eL22 p53 MDM2 RPL11/uL5 RPL5/uL18 |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3616704 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Cao, Bo,Fang, Ziling,Liao, Peng,et al. Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit[J]. ONCOTARGET,2017,8(53). |
| APA | Cao, Bo.,Fang, Ziling.,Liao, Peng.,Zhou, Xiang.,Xiong, Jianping.,...&Lu, Hua.(2017).Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.ONCOTARGET,8(53). |
| MLA | Cao, Bo,et al."Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit".ONCOTARGET 8.53(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论